News

Morgan Stanley Adjusts Ratings for Key Software Players

Morgan Stanley Adjusts Ratings for Key Software Players

Overview of Morgan Stanley's Software Ratings

Morgan Stanley analysts have recently revised their ratings and price targets for several prominent software companies, identifying both substantial opportunities and potential risks associated with GenAI technologies. In this landscape, Atlassian Corp Plc (NASDAQ: TEAM) has emerged as a standout pick for 2025. The brokerage's assessment reflects a strategic analysis of the market dynamics influencing software firms.

Atlassian's Strong Position

Atlassian's rating has been elevated to 'overweight,' with the price target increased significantly from $259 to $315. This adjustment is rooted in the analysts' recognition of the company's potential for sustained growth and operational efficiency. With forecasts indicating a 20% top-line growth, strong free cash flow, and exciting opportunities in broader market applications and product portfolios, Atlassian continues to impress despite its recent 35% stock price surge. This optimism regarding Atlassian aligns with the firm's ability to navigate the complexities of the market.

Market Opportunities and Challenges

The analysts noted that larger consolidators in the software industry are best positioned to capitalize on emerging opportunities while managing risks effectively. This perspective underscores the dynamic nature of the tech landscape, where competition and technological advancements shape the trajectory of growth.

Datadog and Confluent's Downgrades

In contrast to the optimistic outlook for Atlassian, Datadog (NASDAQ: DDOG) has seen its rating downgraded to 'equal-weight.' This decision stems from a careful balancing act between long-term growth prospects in observability and cloud security and the need to address pressing short-term risks. With shares hovering close to the price target of $143, concerns regarding the company's revenue guidance for 2025 and potential spending slowdowns among AI-native customers have tempered analyst expectations.

Awaited Catalysts

Market watchers are keenly awaiting catalysts that could reinvigorate Datadog's upward momentum, such as increased software spending and advancements in AI-driven product cycles. It's imperative for Datadog to leverage these potential drivers to mitigate the short-term hurdles it currently faces.

Confluent's Performance and Outlook

Similarly, Confluent has faced a downgrade to 'equal-weight' despite a generally positive outlook in the data streaming market. Analysts raised concerns about the company's ability to drive the adoption of Flink, a critical component for data processing. Additionally, they expressed cautiousness regarding 2025 revenue growth projections. Although the price target was slightly adjusted from $30 to $33, this reflects a tempered short-term outlook while maintaining a belief in the long-term opportunities within the data streaming sector.

DigitalOcean's Strategic Upgrade

On a more positive note, DigitalOcean has been upgraded to 'overweight,' now boasting a price target of $41. This strategic upgrade is attributed to the company's shift in focus towards larger customer segments, coupled with favorable valuation metrics. DigitalOcean's adaptability in a competitive landscape has made it a noteworthy player in the software sector.

Prospects for OneStream

OneStream has also received an upgraded rating to 'overweight.' Analysts have pinpointed growth tailwinds attributed to the ERP supercycle and advancements in AI-driven products. This positions OneStream favorably for the potential future upward revisions and reflects confidence in its strategic direction.

Frequently Asked Questions

What are Morgan Stanley's recent activities concerning software companies?

Morgan Stanley adjusted ratings and price targets for major software firms, identifying both opportunities and challenges.

Why was Atlassian Corp Plc rated as a top pick?

Analysts see Atlassian's strong growth potential and operational efficiency as key factors in its top pick status for 2025.

What challenges did Datadog and Confluent face?

Both companies faced downgrades due to near-term challenges, including revenue guidance concerns and adoption issues.

Why was DigitalOcean upgraded?

DigitalOcean's upgrade was driven by its strategic shift toward larger clients and favorable valuation metrics.

What does the future hold for OneStream?

OneStream is positioned for potential upward revisions thanks to growth opportunities in ERP and AI-related products.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 5

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 14

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 5

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading

Top 5 Most Recently Viewed Articles

Red Pine Unveils Exciting Gold Discoveries at Wawa Project

Updated Category News Views 177

Red Pine Exploration's Impressive Drilling Results Red Pine Exploration Inc. (TSXV: RPX, OTCQB: RDEXF) is thrilled to announce outstanding results from its ongoing drilling program at the Wawa Gold Project. This Canadian gold exploration company has executed a comprehensive drilling initiative, totaling 2,793 meters across three drill holes, aiming to unlock the full...

Continue Reading
Silver's Backwardation: What It Means for Investors Today

Updated Category News Views 447

Understanding Silver's Current Market Dynamics Recently, silver's futures market revealed a significant shift, entering a state of backwardation not seen for four decades. This phenomenon indicates that the short-term contract price is considerably higher than longer-term futures, reflecting a dramatic demand for immediate physical silver. The difference of $2.88...

Continue Reading
PGIM High Yield Funds Announce Monthly Distributions

Updated Category News Views 508

PGIM Funds Unveil Distribution Plans for Shareholders NEWARK, N.J.--PGIM High Yield Bond Fund, Inc. (NYSE: ISD), PGIM Global High Yield Fund, Inc. (NYSE: GHY), and PGIM Short Duration High Yield Opportunities Fund (NYSE: SDHY) have announced their monthly distributions for December 2024, January, and February 2025. This initiative signifies their commitment to delivering...

Continue Reading
Investors Urged to Act as Altimmune Faces Legal Challenges

Updated Category News Views 156

Important Legal Investigations Concerning Altimmune, Inc. Faruqi & Faruqi, LLP is currently investigating potential claims on behalf of investors who may have suffered financial losses related to Altimmune, Inc. (NASDAQ: ALT). Investors who acquired securities of Altimmune should pay close attention to this matter, as there are critical developments that could affect...

Continue Reading
Conejo Valley Unified Faces Lawsuits Over Assault Inaction

Updated Category News Views 6

Legal Scrutiny Hits Conejo Valley Unified In what feels like a never-ending cycle of educational mishaps, Conejo Valley Unified School District and its Westlake High School find themselves under the harsh spotlight of the legal system. Two lawsuits filed in Ventura County Superior Court are laying bare some serious accusations against them. Former students, using the...

Continue Reading